These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19949822)

  • 1. Effect of mood stabilizers on gene expression in lymphoblastoid cells.
    Sugawara H; Iwamoto K; Bundo M; Ishiwata M; Ueda J; Kakiuchi C; Ishigooka J; Kato T
    J Neural Transm (Vienna); 2010 Feb; 117(2):155-64. PubMed ID: 19949822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood-stabilizers differentially affect housekeeping gene expression in human cells.
    Powell TR; Powell-Smith G; Haddley K; Mcguffin P; Quinn J; Schalkwyk LC; Farmer AE; D'Souza UM
    Int J Methods Psychiatr Res; 2014 Jun; 23(2):279-88. PubMed ID: 24677680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers.
    Zhou R; Gray NA; Yuan P; Li X; Chen J; Chen G; Damschroder-Williams P; Du J; Zhang L; Manji HK
    J Neurosci; 2005 May; 25(18):4493-502. PubMed ID: 15872096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.
    Song N; Boku S; Nakagawa S; Kato A; Toda H; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):183-9. PubMed ID: 22484386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.
    Asghari V; Wang JF; Reiach JS; Young LT
    Brain Res Mol Brain Res; 1998 Jul; 58(1-2):95-102. PubMed ID: 9685595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
    Cui J; Shao L; Young LT; Wang JF
    Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM
    Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mood stabilizer-regulated genes by differential-display PCR.
    Wang JF; Bown CD; Chen B; Young LT
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):65-74. PubMed ID: 11343631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia.
    Washizuka S; Iwamoto K; Kakiuchi C; Bundo M; Kato T
    Neurosci Res; 2009 Mar; 63(3):199-204. PubMed ID: 19135101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
    Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons.
    Wang JF; Shao L; Sun X; Young LT
    J Neurochem; 2004 Mar; 88(6):1477-84. PubMed ID: 15009649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
    Musetti L; Tundo A; Benedetti A; Massimetti G; Cambiali E; Pergentini I; Del Grande C; Dell'Osso L
    Hum Psychopharmacol; 2018 Nov; 33(6):e2676. PubMed ID: 30311959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.
    Shao L; Young LT; Wang JF
    Biol Psychiatry; 2005 Dec; 58(11):879-84. PubMed ID: 16005436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression.
    Du J; Gray NA; Falke C; Yuan P; Szabo S; Manji HK
    Ann N Y Acad Sci; 2003 Nov; 1003():378-80. PubMed ID: 14684466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage.
    Bachmann RF; Wang Y; Yuan P; Zhou R; Li X; Alesci S; Du J; Manji HK
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):805-22. PubMed ID: 19149911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gene expression in mice treated with the mood stabilizer sodium valproate.
    Chetcuti A; Adams LJ; Mitchell PB; Schofield PR
    Int J Neuropsychopharmacol; 2006 Jun; 9(3):267-76. PubMed ID: 15982445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
    Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
    Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
    Lai JS; Zhao C; Warsh JJ; Li PP
    Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems.
    Gilmor ML; Skelton KH; Nemeroff CB; Owens MJ
    J Pharmacol Exp Ther; 2003 May; 305(2):434-9. PubMed ID: 12606697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.